Senior Director Finance Strategic Pricing IM

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:

Strategy & Corporate Development

Job Sub Function:

Strategic Planning

Job Category:

People Leader

All Job Posting Locations:

Titusville, New Jersey, United States of America

Job Description:

Johnson and Johnson North America Pharmaceuticals Group, a part of Johnson & Johnson's Family of Companies, is recruiting for a Senior Finance Director, Janssen US Finance Strategic Pricing, located in Titusville, NJ.

Janssen Pharmaceuticals, Inc. provides medicines for an array of health concerns in several therapeutic areas, including Cardiovascular, Metabolic, Oncology, and Immunology. Please visit www.JanssenPharmaceuticalsInc.com for more information. Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.

The Finance Director will lead, direct, and advise on total Janssen US rebates and discounts expense – totaling over $40B across five therapeutic areas in various stages of the product lifecycle.  This provides financial leadership related to deals to secure patient access to Janssen US brands.  This role will be the primary business partner for the Strategic Customer Group (SCG) Value Access Pricing VP2, Strategic Account Management VP2, Contracting Senior Director, and Inflation Reduction Act (IRA) organization; sitting on their respective leadership teams.  This role will also provide financial leadership for key cross-portfolio initiatives including list price action analysis, long range financial plan strategic pricing and government policy analysis.  The candidate will have significant interaction with the Janssen CFO, Strategic Customer Officer, company Presidents and the Company Group Chair related to material customer deals, LPA analysis, LRFP and government policy analysis.  The Senior Director will also develop, lead and supervise a team of 5 managers and 7 professionals.

Additionally, this role will be the key point of contract for the Inflation Reduction Act and State Policy changes that have a significant impact on the Janssen portfolio.  Specifically, the Inflation Reduction Act (IRA) is a law that was passed in August 2022, and is the largest government policy change to the prescription drug market since the Medicare Modernization Act of 2003. The candidate will regularly present to senior leaders including the Janssen US President, SCG President, TA Presidents, and regional CFO – and occasionally the WW President of Pharm, as well as the Group Finance CFO.   The candidate may also be interacting externally with government personnel in price negotiations.

This position deals with highly confidential information and engages in sensitive conversations with executive stakeholders (CFO, Company Presidents).  The candidate will need an extremely high degree of professional judgement and subject matter expertise given the assumptions and estimates needed to effectively execute the role.

Key Responsibilities:

• Key contact for the Strategic Customer Group Value Access Pricing VP2, Strategic Account Management VP2, Contracting Senior Director, and IRA Organization.

• Financial leader for strategic customer pricing analysis, supporting transactions with a material impact to the Janssen portfolio in the short and long term Frequent exposure to TA Presidents and SCG President during bid reviews.

• NA Pharm Finance and broader finance organizational lead for the Inflation Reduction Act.  Overseeing complex modeling and forecasting of impacts to the portfolio, operational readiness reviews, and coordination of the newly required manufacturer data submission for selected drugs. 

• With respect to Data Submission, will be responsible for coordinating deliverables across the enterprise (Global Sales, Lifetime R&D, Manufacturing & Distribution, Federal Funding), compiling the information for submission to CMS, participating in meetings with CMS, and addressing any follow ups throughout the entire negotiation period for selected assets. 

• Key financial leader for evolving federal and state policy changes, overseeing the financ